
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    Here's a detailed analysis to identify the cell type based on the provided marker list from a human large intestine tissue dataset:<br><br>**Step 1. List the Key Functional Markers:**<br><br>*   **ASCL2 (Achaete-scute homolog 2):** A basic helix-loop-helix (bHLH) transcription factor. In the intestine, ASCL2 is a critical regulator of intestinal stem cell (ISC) maintenance and proliferation. It is highly expressed in LGR5+ ISCs and is essential for their self-renewal and differentiation into various epithelial lineages.<br>*   **LGR5 (Leucine-rich repeat-containing G protein-coupled receptor 5):** A canonical marker for actively cycling intestinal stem cells located at the crypt base. LGR5+ cells are multipotent and can give rise to all intestinal epithelial cell types. Its high expression is a strong indicator of stemness.<br>*   **SMOC2 (SPARC-related modular calcium-binding protein 2):** While not exclusively a stem cell marker, SMOC2 has been shown to be highly expressed in intestinal crypts and is involved in Wnt signaling, which is crucial for intestinal stem cell maintenance and proliferation. It can be considered a marker of proliferative crypt cells.<br>*   **NOS2 (Nitric Oxide Synthase 2, inducible):** While NOS2 can be expressed in various cell types, including immune cells, its presence in the context of intestinal stem cell markers might suggest a role in regulating the stem cell niche or responding to local inflammatory signals within the crypt. However, its primary role here is less direct for cell type identification compared to ASCL2 and LGR5.<br>*   **ALDH1B1 (Aldehyde Dehydrogenase 1 Family Member B1):** Aldehyde dehydrogenases (ALDHs) are often associated with stem cell populations across various tissues, including the intestine, due to their role in detoxification and maintaining cellular homeostasis. ALDH activity is a known marker for certain stem cell populations.<br>*   **PTPRO (Protein Tyrosine Phosphatase Receptor Type O):** While PTPRO is a receptor-type protein tyrosine phosphatase, its specific role as a definitive marker for a particular intestinal cell type is less established compared to the other markers. It might be involved in signaling pathways relevant to intestinal epithelial function or differentiation, but its direct utility for cell type identification here is limited without further context.<br>*   **AQP1 (Aquaporin 1):** A water channel protein. AQP1 is typically expressed in endothelial cells, red blood cells, and some epithelial cells involved in fluid transport (e.g., kidney, choroid plexus). Its presence in this list, given the other strong stem cell markers, is somewhat unexpected for a pure stem cell population. It might indicate contamination from other cell types or a specific subpopulation with fluid transport capabilities, or perhaps a role in the stem cell niche. However, it's not a primary stem cell marker.<br><br>**Step 2. List the Key Cell Type Markers:**<br><br>Based on the provided list, the most prominent and specific markers point towards intestinal epithelial cells, particularly those with stem cell characteristics.<br><br>*   **LGR5:** Definitive marker for actively cycling intestinal stem cells.<br>*   **ASCL2:** Critical transcription factor for intestinal stem cell maintenance and proliferation, highly co-expressed with LGR5.<br>*   **SMOC2:** Associated with proliferative crypt cells and Wnt signaling, supporting a stem/progenitor cell identity.<br>*   **ALDH1B1:** General stem cell marker, often associated with ALDH activity in stem cell populations.<br><br>The remaining markers (UQCRFS1P1, SDHDP6, RPSAP15, PPIAP31, RPL41P5, PPIAP11, EEF1A1P11, SMOC2, EEF1A1P9, CDCA7, EEF1A1P12, NPM1P6, HMGN2P3, PPIAP29, RPL9P7, NHP2P1, PEBP1P2, EEF1A1P19, FABP5P7, EIF5AP4, HMGN2P6, HNRNPA1P4, CYCSP55, HMGN1P38, RPL7P6, RPL23AP65, HMGN2P4, HMGN1P36, RPSAP8, GAPDHP1, RPL10P9, CACYBPP2) are largely ribosomal proteins, pseudogenes, or general housekeeping genes (e.g., GAPDHP1 is a pseudogene of GAPDH). Their high expression often reflects high metabolic activity and protein synthesis, which is characteristic of rapidly proliferating cells like stem cells or progenitor cells. CDCA7 (Cell Division Cycle Associated 7) is also consistent with a highly proliferative cell type.<br><br>**Step 3. Cross-reference Known Databases:**<br><br>*   **LGR5 and ASCL2:** Extensive literature and scRNA-seq databases (e.g., Human Cell Atlas, Tabula Sapiens, specific intestinal scRNA-seq datasets) consistently identify LGR5 and ASCL2 as co-expressed markers for intestinal stem cells located at the crypt base. They are the cornerstone markers for this cell population.<br>*   **SMOC2:** Often found enriched in intestinal crypts and associated with proliferative cells, supporting the stem/progenitor cell identity.<br>*   **ALDH1B1:** While ALDH activity is a broader stem cell marker, ALDH1B1 has been implicated in intestinal stem cell function and is found in some intestinal stem/progenitor populations.<br>*   **NOS2:** Can be expressed in various intestinal cell types, including some epithelial cells under inflammatory conditions, or in immune cells. Its presence here is less specific for stem cells but doesn't rule them out.<br>*   **AQP1:** Primarily associated with endothelial cells or specific epithelial cells involved in fluid transport. Its presence in a list dominated by stem cell markers is unusual for a pure stem cell population and might suggest a minor contaminating population or a specific niche-related function. However, given the strong stem cell markers, it's likely a minor or less specific signal.<br><br>**Step 4. Determine the Most Probable General Cell Type:**<br><br>Based on the overwhelming evidence from **LGR5** and **ASCL2**, the most probable general cell type is **Intestinal Epithelial Stem Cells**. The presence of other proliferative markers (SMOC2, CDCA7, ribosomal proteins) further supports this.<br><br>**Step 5. Identify the Top 3 Most Probable Sub Cell Types:**<br><br>Given the strong markers, the sub-types will be variations or states of intestinal stem cells.<br><br>1.  **Most Likely: LGR5+ Intestinal Stem Cells (ISCs):** This is the most direct and strongly supported annotation. LGR5 is the canonical marker for actively cycling, multipotent stem cells at the crypt base. ASCL2 is a key transcription factor driving their stemness and proliferation. The high expression of ribosomal proteins and CDCA7 is consistent with their high proliferative rate.<br>2.  **Second Most Likely: Progenitor Cells (Transit-Amplifying Cells):** While LGR5 and ASCL2 are specific for stem cells, some of these markers (e.g., SMOC2, high ribosomal protein expression, CDCA7) are also characteristic of rapidly dividing transit-amplifying (TA) cells, which are immediate progeny of ISCs. These cells are still highly proliferative but have lost some of their multipotency and are committed to differentiation. However, the presence of LGR5 and ASCL2 pushes the annotation more towards the stem cell end of the spectrum.<br>3.  **Third Most Likely: Secretory Progenitor Cells (e.g., early Goblet/Paneth cell progenitors):** While less directly supported by the top markers, some intestinal stem cells can be biased towards specific lineages. If there were markers like MUC2 (Goblet) or Lyz1 (Paneth) further down the list, this would be more plausible. However, LGR5+ ISCs are multipotent and can give rise to all lineages, so this represents a potential differentiation trajectory from the stem cell pool. The current markers don't strongly point to a specific secretory lineage bias, but it's a possibility within the broader stem/progenitor compartment.<br><br>**Most Likely Subtype:** **LGR5+ Intestinal Stem Cells (ISCs)**. The co-expression of LGR5 and ASCL2 is the defining characteristic of this population in the large intestine.<br><br>**Step 6. Provide a Concise Summary of Your Analysis:**<br><br>The provided marker list from human large intestine tissue strongly indicates a population of **LGR5+ Intestinal Stem Cells (ISCs)**. Key markers such as **LGR5** and **ASCL2** are canonical for actively cycling, multipotent stem cells located at the crypt base, essential for intestinal epithelial renewal. The presence of **SMOC2** and **ALDH1B1** further supports a stem/progenitor cell identity, with SMOC2 being associated with proliferative crypt cells and ALDH1B1 with general stem cell properties. High expression of ribosomal proteins and cell cycle-associated genes like **CDCA7** is consistent with the high proliferative activity of ISCs. While **NOS2** and **AQP1** are present, they are less specific for stem cells and likely represent minor signals or broader cellular functions within the crypt environment, not detracting from the primary stem cell signature. The top three most probable sub-cell types are LGR5+ Intestinal Stem Cells (most likely), followed by Progenitor Cells (Transit-Amplifying Cells), and then Secretory Progenitor Cells. The most likely specific subtype is **LGR5+ Intestinal Stem Cells**.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Intestinal Epithelial Stem Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>LGR5+ Intestinal Stem Cells (ISCs)</li><li>Progenitor Cells (Transit-Amplifying Cells)</li><li>Secretory Progenitor Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">98</div>
                        <div class="scoring-content">
                            The annotation for the provided single-cell data from human large intestine tissue is exceptionally strong and well-justified.<br><br>**Strengths:**<br><br>1.  **Correctness and Scientific Accuracy:** The identification of "LGR5+ Intestinal Stem Cells (ISCs)" as the main and most likely sub-cell type is highly accurate and supported by extensive scientific literature. LGR5 and ASCL2 are indeed canonical and highly specific markers for actively cycling intestinal stem cells.<br>2.  **Balanced Consideration of Markers:** The analysis demonstrates a sophisticated understanding of marker hierarchy. It correctly prioritizes LGR5 and ASCL2 as the "key functional markers" and acknowledges their definitive role, while appropriately downplaying less specific markers like NOS2 and AQP1. The inclusion of SMOC2 and ALDH1B1 as supporting stem/progenitor markers is also accurate.<br>3.  **Handling of Non-Specific Markers:** The agent correctly identifies a large number of markers as ribosomal proteins, pseudogenes, or general housekeeping genes (e.g., GAPDHP1, CDCA7). It interprets their high expression as indicative of high metabolic activity and protein synthesis, which is characteristic of rapidly proliferating cells like stem cells, demonstrating an insightful understanding of cellular physiology beyond just specific markers.<br>4.  **Comprehensive View of Cell Populations:** The analysis not only identifies the primary cell type but also considers plausible related "sub-cell types" and "possible mixed cell types" (though none were strongly indicated as mixed, which is also a valid conclusion). The discussion of Transit-Amplifying Cells and Secretory Progenitor Cells shows an awareness of the differentiation continuum within the intestinal crypt.<br>5.  **Consideration of Marker Rank:** The analysis implicitly considers the rank of markers by highlighting the importance of LGR5 and ASCL2, which appear early in the provided list. This shows an understanding that markers appearing first might be more significant, although it doesn't explicitly state this as a rule. The detailed explanation for each of the primary markers (LGR5, ASCL2, SMOC2, NOS2, ALDH1B1, PTPRO, AQP1) is thorough.<br>6.  **Robust Justification:** Each step of the analysis is clearly articulated, from listing key functional markers to cross-referencing known databases. The "Concise Summary" effectively synthesizes all the points, providing a very strong case for the final annotation.<br><br>**Minor Weaknesses/Areas for Nuance (very minor):**<br><br>1.  **Explicitly Stating Marker Rank Consideration:** While the analysis implicitly handles marker rank well by focusing on LGR5 and ASCL2, an explicit statement about the importance of markers appearing first in the list, if that was a guiding principle, would have been a perfect addition to the methodology. However, the current approach is effective.<br>2.  **PTPRO and AQP1 Interpretation:** The analysis correctly identifies PTPRO as less established and AQP1 as unusual for pure stem cells. While the interpretation of AQP1 as potential "contamination" or "specific subpopulation" is reasonable, further speculation on its specific role within the stem cell niche or as a minor co-expressed gene in a specific ISC state (though less likely) could have been explored, but this is a very minor point and the current assessment is sound.<br><br>Overall, the annotation is outstanding, demonstrating deep biological knowledge, critical thinking, and an ability to synthesize complex marker information into a coherent and accurate cell type identification.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    